HEADER ANTIMICROBIAL PROTEIN 01-MAR-10 2KUY TITLE STRUCTURE OF GLYCOCIN F CAVEAT 2KUY NAG A 44 HAS WRONG CHIRALITY AT ATOM C5 NAG A 44 HAS WRONG CAVEAT 2 2KUY CHIRALITY AT ATOM C4 NAG A 44 HAS WRONG CHIRALITY AT ATOM CAVEAT 3 2KUY C2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PREBACTERIOCIN GLYCOCIN F; COMPND 3 CHAIN: A SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: LACTOBACILLUS PLANTARUM; SOURCE 3 ORGANISM_TAXID: 1590 KEYWDS BACTERIOCIN, GLYCOSYLATION, LACTOBACILLUS, S-LINKED, ANTIMICROBIAL KEYWDS 2 PROTEIN EXPDTA SOLUTION NMR NUMMDL 12 AUTHOR H.VENUGOPAL,P.EDWARDS,M.SCHWALBE,J.CLARIDGE,J.STEPPER,M.PATCHETT, AUTHOR 2 T.LOO,D.LIBICH,G.NORRIS,S.PASCAL REVDAT 5 14-JUN-23 2KUY 1 HETSYN REVDAT 4 29-JUL-20 2KUY 1 CAVEAT COMPND REMARK HETNAM REVDAT 4 2 1 LINK SITE REVDAT 3 05-FEB-20 2KUY 1 REMARK LINK REVDAT 2 18-MAY-11 2KUY 1 COMPND DBREF TITLE REVDAT 1 04-MAY-11 2KUY 0 JRNL AUTH H.VENUGOPAL,P.J.EDWARDS,M.SCHWALBE,J.K.CLARIDGE,D.S.LIBICH, JRNL AUTH 2 J.STEPPER,T.LOO,M.L.PATCHETT,G.E.NORRIS,S.M.PASCAL JRNL TITL STRUCTURAL, DYNAMIC, AND CHEMICAL CHARACTERIZATION OF A JRNL TITL 2 NOVEL S-GLYCOSYLATED BACTERIOCIN. JRNL REF BIOCHEMISTRY V. 50 2748 2011 JRNL REFN ISSN 0006-2960 JRNL PMID 21395300 JRNL DOI 10.1021/BI200217U REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : ARIA, ARIA REMARK 3 AUTHORS : LINGE, O'DONOGHUE AND NILGES (ARIA), LINGE, REMARK 3 O'DONOGHUE AND NILGES (ARIA) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2KUY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-MAR-10. REMARK 100 THE DEPOSITION ID IS D_1000101604. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 310 REMARK 210 PH : NULL REMARK 210 IONIC STRENGTH : 0 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 3 MM GLYCOCIN F-1, 40% REMARK 210 ACETONITRILE 50% H2O 10% D20 REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 2D 1H-13C HSQC; REMARK 210 2D 1H-1H TOCSY; 2D 1H-1H NOESY; REMARK 210 2D DQF-COSY; 2D 1H-13C HMBC; 2D REMARK 210 1H-13C H2BC REMARK 210 SPECTROMETER FIELD STRENGTH : 700 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NULL REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 20 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 12 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 PRO A 2 177.03 -49.12 REMARK 500 1 ALA A 3 78.73 -168.69 REMARK 500 1 CYS A 5 -84.26 -62.50 REMARK 500 1 ALA A 14 44.43 -175.36 REMARK 500 1 ASP A 17 92.24 176.17 REMARK 500 1 SER A 18 -79.45 -132.75 REMARK 500 1 TYR A 23 -69.78 -91.56 REMARK 500 1 PHE A 29 -70.29 -108.66 REMARK 500 1 SER A 35 96.38 -53.88 REMARK 500 1 SER A 36 -62.91 -170.76 REMARK 500 1 SER A 38 -175.04 -66.66 REMARK 500 1 SER A 40 69.74 -157.82 REMARK 500 1 HIS A 42 84.26 52.36 REMARK 500 2 CYS A 12 170.44 -48.57 REMARK 500 2 ALA A 14 -69.33 69.63 REMARK 500 2 ASP A 17 65.24 60.68 REMARK 500 2 TYR A 23 -73.02 -82.09 REMARK 500 2 ILE A 31 72.83 -154.75 REMARK 500 2 LYS A 32 34.12 -155.31 REMARK 500 2 HIS A 33 91.42 66.43 REMARK 500 2 SER A 35 149.88 -179.45 REMARK 500 2 SER A 39 -59.80 -130.39 REMARK 500 2 SER A 40 62.58 66.07 REMARK 500 2 TYR A 41 -76.55 -115.84 REMARK 500 3 ALA A 3 45.60 -94.79 REMARK 500 3 CYS A 5 -72.52 -60.26 REMARK 500 3 CYS A 12 -74.14 -51.76 REMARK 500 3 ASP A 17 49.54 -91.51 REMARK 500 3 TYR A 23 -71.02 -75.69 REMARK 500 3 LYS A 32 90.46 49.88 REMARK 500 3 HIS A 33 94.01 -175.35 REMARK 500 3 SER A 36 76.26 54.01 REMARK 500 3 HIS A 42 -54.75 -145.12 REMARK 500 4 ALA A 3 78.86 -155.68 REMARK 500 4 ASP A 17 78.68 -62.90 REMARK 500 4 TYR A 23 -64.71 -97.75 REMARK 500 4 PHE A 29 -83.33 -87.55 REMARK 500 4 SER A 39 -67.34 -134.69 REMARK 500 5 ALA A 14 151.22 68.44 REMARK 500 5 ASP A 17 53.26 -161.27 REMARK 500 5 TYR A 25 -83.15 -63.46 REMARK 500 5 PHE A 29 121.05 78.55 REMARK 500 5 HIS A 33 97.95 66.92 REMARK 500 5 SER A 39 -61.30 -154.72 REMARK 500 5 SER A 40 -46.99 -179.40 REMARK 500 5 HIS A 42 75.77 51.02 REMARK 500 6 PRO A 2 -168.83 -76.53 REMARK 500 6 CYS A 5 -77.03 -53.35 REMARK 500 6 CYS A 12 151.97 -48.63 REMARK 500 6 ALA A 14 69.47 75.56 REMARK 500 REMARK 500 THIS ENTRY HAS 109 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 16747 RELATED DB: BMRB DBREF 2KUY A 1 43 UNP E9K9Z1 E9K9Z1_LACPL 22 64 SEQRES 1 A 43 LYS PRO ALA TRP CYS TRP TYR THR LEU ALA MET CYS GLY SEQRES 2 A 43 ALA GLY TYR ASP SER GLY THR CYS ASP TYR MET TYR SER SEQRES 3 A 43 HIS CYS PHE GLY ILE LYS HIS HIS SER SER GLY SER SER SEQRES 4 A 43 SER TYR HIS CYS MODRES 2KUY SER A 18 SER GLYCOSYLATION SITE HET NAG A 44 28 HET NAG A 45 28 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 2 NAG 2(C8 H15 N O6) HELIX 1 1 TRP A 4 MET A 11 1 8 HELIX 2 2 GLY A 19 GLY A 30 1 12 SSBOND 1 CYS A 5 CYS A 28 1555 1555 2.03 SSBOND 2 CYS A 12 CYS A 21 1555 1555 2.03 LINK OG SER A 18 C1 NAG A 44 1555 1555 1.50 LINK SG CYS A 43 C1 NAG A 45 1555 1555 1.80 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1